Discovery of Potent Inhibitors for a Key Enzyme in Metabolic Syndrome
Author Information
Author(s): Su Xiangdong, Vicker Nigel, Thomas Mark P, Pradaux-Caggiano Fabienne, Halem Heather, Culler Michael D, Potter Barry V L
Primary Institution: University of Bath
Hypothesis
Can adamantyl heterocyclic ketones serve as effective inhibitors of 11β-Hydroxysteroid Dehydrogenase Type 1?
Conclusion
The study identified several adamantyl heterocyclic ketones as potent and selective inhibitors of 11β-HSD1, which may help in treating metabolic syndrome.
Supporting Evidence
- Lead compounds displayed low nanomolar inhibition against human and mouse 11β-HSD1.
- Selected inhibitors showed moderate metabolic stability in human liver microsomes.
- Compounds were tested for selectivity against other hydroxysteroid dehydrogenases.
Takeaway
Scientists found new compounds that can block a specific enzyme linked to obesity and diabetes, which could help people with these conditions.
Methodology
The study involved synthesizing and testing various adamantyl heterocyclic ketones for their inhibitory effects on 11β-HSD1 using cell-based assays.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website